mAb (D5); Mouse anti Human Cathepsin B Antibody; WB; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab093155-10μl | 10μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $66.90 | |
| Ab093155-20μl | 20μl | In stock | $89.90 | |
| Ab093155-50μl | 50μl | In stock | $189.90 | |
| Ab093155-100μl | 100μl | In stock | $279.90 | |
| Ab093155-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,299.90 |
mAb (D5); Mouse anti Human Cathepsin B Antibody; WB; Unconjugated
| Product Name | Cathepsin B Mouse mAb - Primary antibody, specific to Cathepsin B, Mouse IgG1 |
|---|---|
| Synonyms | Amyloid precursor protein secretase antibody; APP secretase antibody; APPS antibody; CATB_HUMAN antibody; Cathepsin B heavy chain antibody; Cathepsin B1 antibody; CathepsinB antibody; CPSB antibody; CTSB antibody; cysteine protease antibody; OTTHUMP000001 |
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Azide Free, High performance, Lot by Lot |
| Host species | Mouse |
| Specificity | Cathepsin B |
| Immunogen | Recombinant Cathepsin B expresed in E.coli (AA 129-333) |
| Positive Control | WB: A549, HeLa, Hep G2, K562, A431, NIH/3T3 and C6 cell lysates. |
| Conjugation | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™, Validated, 高性能 |
| Product Description | Mouse anti Human Cathepsin B Antibody, Monoclonal (D5), could be used for WB and so on. Application WB: 0.01-2 µg/mL Protein Function Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis. |
| Isotype | Mouse IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A + Protein G purified |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Cathepsin B Mouse mAb (Ab093155) - Western Blot
All lanes: Cathepsin B Mouse mAb (Ab093155) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138040) at 1/20000 dilution
Predicted band size: 37 kDa
Observed band size: 25, 28, 34, 49 kDa
Exposure time: 34.7 s
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Application | Dilution info |
|---|---|
| WB |
0.01-2 µg/mL
|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ23F1201962 | Certificate of Analysis | Dec 08, 2023 | Ab093155 |
| ZJ23F1201960 | Certificate of Analysis | Dec 08, 2023 | Ab093155 |
| ZJ23F1201961 | Certificate of Analysis | Dec 08, 2023 | Ab093155 |
| 1. Ovat A, Li ZZ, Hampton CY, Asress SA, Fernández FM, Glass JD, Powers JC. (2010) Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.. J Med Chem, 53 (17): (6326-36). [PMID:20690647] |
| 2. Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H. (2009) Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.. J Med Chem, 52 (18): (5732-47). [PMID:19715320] |
| 3. Mott BT, Ferreira RS, Simeonov A, Jadhav A, Ang KK, Leister W, Shen M, Silveira JT, Doyle PS, Arkin MR et al.. (2010) Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.. J Med Chem, 53 (1): (52-60). [PMID:19908842] |
| 4. Méthot N, Rubin J, Guay D, Beaulieu C, Ethier D, Reddy TJ, Riendeau D, Percival MD. (2007) Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.. J Biol Chem, 282 (29): (20836-46). [PMID:17535802] |
| 5. Elie BT, Gocheva V, Shree T, Dalrymple SA, Holsinger LJ, Joyce JA. (2010) Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.. Biochimie, 92 (11): (1618-24). [PMID:20447439] |
| 6. Izidor Sosič,Bojana Mirković,Katharina Arenz,Bogdan Stefane,Janko Kos,Stanislav Gobec. (2012-12-21) Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.. Journal of medicinal chemistry, 56 ((2)): (521-533). [PMID:23252745] |
| 7. Levente E Dókus,Dóra K Menyhárd,Ágnes Tantos,Ferenc Hudecz,Zoltán Bánóczi. (2014-06-11) Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.. European journal of medicinal chemistry, 82 (274-280). [PMID:24915003] |
| 8. Xiao-Yu Yuan,Zhongyuan Ren,Yuqing Wu,Carole Bougault,Leyre Brizuela,David Magne,René Buchet,Saida Mebarek. (2019-02-19) Design, synthesis and biological evaluation of inhibitors of cathepsin K on dedifferentiated chondrocytes.. Bioorganic & medicinal chemistry, 27 ((6)): (1034-1042). [PMID:30773420] |
| 9. Mendonca RV, Venkatraman S, Palmer JT.. (2002) Novel route to the synthesis of peptides containing 2-amino-1'-hydroxymethyl ketones and their application as cathepsin K inhibitors.. Bioorg Med Chem Lett, 12 (20): (2887-2891). [PMID:12270170] |
| 10. Greenspan PD, Clark KL, Tommasi RA, Cowen SD, McQuire LW, Farley DL, van Duzer JH, Goldberg RL, Zhou H, Du Z, Fitt JJ, Coppa DE, Fang Z, Macchia W, Zhu L, Capparelli MP, Goldstein R, Wigg AM, Doughty JR, Bohacek RS, Knap AK.. (2001) Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.. J Med Chem, 44 (26): (4524-4534). [PMID:11741472] |
| 11. Marquis RW, Ru Y, Zeng J, Trout RE, LoCastro SM, Gribble AD, Witherington J, Fenwick AE, Garnier B, Tomaszek T, Tew D, Hemling ME, Quinn CJ, Smith WW, Zhao B, McQueney MS, Janson CA, D'Alessio K, Veber DF.. (2001) Cyclic ketone inhibitors of the cysteine protease cathepsin K.. J Med Chem, 44 (5): (725-736). [PMID:11262083] |
| 12. Huang L, Lee A, Ellman JA.. (2002) Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis.. J Med Chem, 45 (3): (676-684). [PMID:11806719] |
| 13. Robichaud J, Oballa R, Prasit P, Falgueyret JP, Percival MD, Wesolowski G, Rodan SB, Kimmel D, Johnson C, Bryant C, Venkatraman S, Setti E, Mendonca R, Palmer JT.. (2003) A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.. J Med Chem, 46 (17): (3709-3727). [PMID:12904076] |
| 14. Barrett DG, Catalano JG, Deaton DN, Long ST, McFadyen RB, Miller AB, Miller LR, Wells-Knecht KJ, Wright LL.. (2005) A structural screening approach to ketoamide-based inhibitors of cathepsin K.. Bioorg Med Chem Lett, 15 (9): (2209-2213). [PMID:15837295] |
| 15. Palmer JT, Bryant C, Wang DX, Davis DE, Setti EL, Rydzewski RM, Venkatraman S, Tian ZQ, Burrill LC, Mendonca RV, Springman E, McCarter J, Chung T, Cheung H, Janc JW, McGrath M, Somoza JR, Enriquez P, Yu ZW, Strickley RM, Liu L, Venuti MC, Percival MD, Falgueyret JP, Prasit P, Oballa R, Riendeau D, Young RN, Wesolowski G, Rodan SB, Johnson C, Kimmel DB, Rodan G.. (2005) Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.. J Med Chem, 48 (24): (7520-7534). [PMID:16302794] |
| 16. Falgueyret JP, Desmarais S, Oballa R, Black WC, Cromlish W, Khougaz K, Lamontagne S, Massé F, Riendeau D, Toulmond S, Percival MD.. (2005) Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.. J Med Chem, 48 (24): (7535-7543). [PMID:16302795] |
| 17. Palmer JT, Hirschbein BL, Cheung H, McCarter J, Janc JW, Yu ZW, Wesolowski G.. (2006) Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.. Bioorg Med Chem Lett, 16 (11): (2909-2914). [PMID:16546382] |
| 18. Setti EL, Venkatraman S, Palmer JT, Xie X, Cheung H, Yu W, Wesolowski G, Robichaud J.. (2006) Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K.. Bioorg Med Chem Lett, 16 (16): (4296-4299). [PMID:16750630] |
| 19. Mallari JP, Shelat AA, Obrien T, Caffrey CR, Kosinski A, Connelly M, Harbut M, Greenbaum D, McKerrow JH, Guy RK.. (2008) Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.. J Med Chem, 51 (3): (545-552). [PMID:18173229] |
| 20. Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP.. (2008) Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.. J Med Chem, 51 (14): (4150-4169). [PMID:18588282] |
| 21. Donkor IO, Korukonda R.. (2008) Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.. Bioorg Med Chem Lett, 18 (17): (4806-4808). [PMID:18694642] |
| 22. Mallari JP, Shelat AA, Kosinski A, Caffrey CR, Connelly M, Zhu F, McKerrow JH, Guy RK.. (2009) Structure-guided development of selective TbcatB inhibitors.. J Med Chem, 52 (20): (6489-6493). [PMID:19769357] |
| 23. Kishore Kumar GD, Chavarria GE, Charlton-Sevcik AK, Arispe WM, Macdonough MT, Strecker TE, Chen SE, Siim BG, Chaplin DJ, Trawick ML, Pinney KG.. (2010) Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.. Bioorg Med Chem Lett, 20 (4): (1415-1419). [PMID:20089402] |
| 24. Rankovic Z, Cai J, Kerr J, Fradera X, Robinson J, Mistry A, Hamilton E, McGarry G, Andrews F, Caulfield W, Cumming I, Dempster M, Waller J, Scullion P, Martin I, Mitchell A, Long C, Baugh M, Westwood P, Kinghorn E, Bruin J, Hamilton W, Uitdehaag J, van Zeeland M, Potin D, Saniere L, Fouquet A, Chevallier F, Deronzier H, Dorleans C, Nicolai E.. (2010) Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.. Bioorg Med Chem Lett, 20 (5): (1524-1527). [PMID:20149657] |
| 25. Rankovic Z, Cai J, Fradera X, Dempster M, Mistry A, Mitchell A, Long C, Hamilton E, King A, Boucharens S, Jamieson C, Gillespie J, Cumming I, Uitdehaag J, van Zeeland M.. (2010) Dioxo-triazines as a novel series of cathepsin K inhibitors.. Bioorg Med Chem Lett, 20 (5): (1488-1490). [PMID:20153187] |
| 26. Dossetter AG, Beeley H, Bowyer J, Cook CR, Crawford JJ, Finlayson JE, Heron NM, Heyes C, Highton AJ, Hudson JA, Jestel A, Kenny PW, Krapp S, Martin S, MacFaul PA, McGuire TM, Gutierrez PM, Morley AD, Morris JJ, Page KM, Ribeiro LR, Sawney H, Steinbacher S, Smith C, Vickers M.. (2012) (1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis.. J Med Chem, 55 (14): (6363-6374). [PMID:22742641] |
| 27. Barthel BL, Rudnicki DL, Kirby TP, Colvin SM, Burkhart DJ, Koch TH.. (2012) Synthesis and biological characterization of protease-activated prodrugs of doxazolidine.. J Med Chem, 55 (14): (6595-6607). [PMID:22742660] |
| 28. Viswanathan K, Hoover DJ, Hwang J, Wisniewski ML, Ikonne US, Bahr BA, Wright DL.. (2012) Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.. ACS Med Chem Lett, 3 (11): (920-924). [PMID:24900408] |
| 29. Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H.. (2013) Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.. J Med Chem, 56 (3): (1276-1290). [PMID:23350733] |
| 30. Song J, Jones LM, Chavarria GE, Charlton-Sevcik AK, Jantz A, Johansen A, Bayeh L, Soeung V, Snyder LK, Lade SD, Chaplin DJ, Trawick ML, Pinney KG.. (2013) Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.. Bioorg Med Chem Lett, 23 (9): (2801-2807). [PMID:23540644] |
| 31. Miller B, Friedman AJ, Choi H, Hogan J, McCammon JA, Hook V, Gerwick WH.. (2014) The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.. J Nat Prod, 77 (1): (92-99). [PMID:24364476] |
| 32. Scarbaci K, Troiano V, Micale N, Ettari R, Tamborini L, Di Giovanni C, Cerchia C, Grasso S, Novellino E, Schirmeister T, Lavecchia A, Zappalà M.. (2014) Identification of a new series of amides as non-covalent proteasome inhibitors.. Eur J Med Chem, 76 (1-9). [PMID:24561716] |
| 33. Newton GK, Perrior TR, Jenkins K, Major MR, Key RE, Stewart MR, Firth-Clark S, Lloyd SM, Zhang J, Francis-Newton NJ, Richardson JP, Chen J, Lai P, Garrod DR, Robinson C.. (2014) The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma.. J Med Chem, 57 (22): (9447-9462). [PMID:25365789] |
| 34. Burger MC, Fernandes JB, da Silva MF, Escalante A, Prudhomme J, Le Roch KG, Izidoro MA, Vieira PC.. (2014) Structures and bioactivities of dihydrochalcones from Metrodorea stipularis.. J Nat Prod, 77 (11): (2418-2422). [PMID:25375026] |
| 35. Raghav N, Singh M.. (2014) SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.. Bioorg Med Chem, 22 (15): (4233-4245). [PMID:24913985] |
| 36. Parker EN, Song J, Kishore Kumar GD, Odutola SO, Chavarria GE, Charlton-Sevcik AK, Strecker TE, Barnes AL, Sudhan DR, Wittenborn TR, Siemann DW, Horsman MR, Chaplin DJ, Trawick ML, Pinney KG.. (2015) Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.. Bioorg Med Chem, 23 (21): (6974-6992). [PMID:26462052] |
| 37. Giroud M, Dietzel U, Anselm L, Banner D, Kuglstatter A, Benz J, Blanc JB, Gaufreteau D, Liu H, Lin X, Stich A, Kuhn B, Schuler F, Kaiser M, Brun R, Schirmeister T, Kisker C, Diederich F, Haap W.. (2018) Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.. J Med Chem, 61 (8): (3350-3369). [PMID:29590750] |
| 38. Capuzzi SJ, Sun W, Muratov EN, Martínez-Romero C, He S, Zhu W, Li H, Tawa G, Fisher EG, Xu M, Shinn P, Qiu X, García-Sastre A, Zheng W, Tropsha A.. (2018) Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.. J Med Chem, 61 (8): (3582-3594). [PMID:29624387] |
| 39. Hovhannisyan AA, Pham TH, Bouvier D, Tan X, Touhar S, Mkryan GG, Dallakyan AM, El Amri C, Melikyan GS, Reboud-Ravaux M, Bouvier-Durand M.. (2017) Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits.. Bioorg Med Chem Lett, 27 (23): (5172-5178). [PMID:29113763] |
| 40. Sosič I, Mitrović A, Ćurić H, Knez D, Brodnik Žugelj H, Štefane B, Kos J, Gobec S.. (2018) Cathepsin B inhibitors: Further exploration of the nitroxoline core.. Bioorg Med Chem Lett, 28 (7): (1239-1247). [PMID:29503024] |
| 41. Galibert M, Wartenberg M, Lecaille F, Saidi A, Mavel S, Joulin-Giet A, Korkmaz B, Brömme D, Aucagne V, Delmas AF, Lalmanach G.. (2018) Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S.. Eur J Med Chem, 144 (201-210). [PMID:29272750] |
| 42. Chowdhury SR, Kennedy S, Zhu K, Mishra R, Chuong P, Nguyen AU, Kathman SG, Statsyuk AV.. (2019) Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.. Bioorg Med Chem Lett, 29 (1): (36-39). [PMID:30455147] |
| 43. van de Plassche MAT, O'Neill TJ, Seeholzer T, Turk B, Krappmann D, Verhelst SHL.. (2020) Use of Non-Natural Amino Acids for the Design and Synthesis of a Selective, Cell-Permeable MALT1 Activity-Based Probe.. J Med Chem, 63 (8): (3996-4004). [PMID:32227886] |
| 44. Hou W, Sun H, Ma Y, Liu C, Zhang Z.. (2019) Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.. J Med Chem, 62 (12): (5901-5919). [PMID:31145622] |
| 45. Fonović UP,Knez D,Hrast M,Zidar N,Proj M,Gobec S,Kos J. (2020) Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X.. Eur J Med Chem, 193 (112218-112218). [PMID:32208223] |
| 46. Quancard J,Simic O,Pissot Soldermann C,Aichholz R,Blatter M,Renatus M,Erbel P,Melkko S,Endres R,Sorge M,Kieffer L,Wagner T,Beltz K,Mcsheehy P,Wartmann M,Régnier CH,Calzascia T,Radimerski T,Bigaud M,Weiss A,Bornancin F,Schlapbach A. (2020) Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood.. J Med Chem, 63 (23): (14594-14608). [PMID:33216547] |
| 47. Moin, K K and 5 more authors.. (1992) Human tumour cathepsin B. Comparison with normal liver cathepsin B.. The Biochemical journal, (15): [PMID:1637335] |
| 48. Musil, D D and 9 more authors.. (1991) The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.. The EMBO journal, [PMID:1868826] |
| 49. Fong, D D, Calhoun, D H DH, Hsieh, W T WT, Lee, B B and Wells, R D RD.. (1986) Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:3010323] |
| 50. Chan, S J SJ, San Segundo, B B, McCormick, M B MB and Steiner, D F DF.. (1986) Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:3463996] |
| 51. Ritonja, A A, Popovic, T T, Turk, V V, Wiedenmann, K K and Machleidt, W W.. (1985) Amino acid sequence of human liver cathepsin B.. FEBS letters, (11): [PMID:3972105] |
| 52. Cao, L L and 5 more authors.. (1994) Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene.. Gene, (25): [PMID:8112600] |
| 53. Turk, D D, Podobnik, M M, Kuhelj, R R, Dolinar, M M and Turk, V V.. (1996) Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.. FEBS letters, (22): [PMID:8617355] |
| 54. Podobnik, M M, Kuhelj, R R, Turk, V V and Turk, D D.. (1997) Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.. Journal of molecular biology, (5): [PMID:9299326] |
| 55. Guo, Rong R and 5 more authors.. (2002) Inhibition of MEPE cleavage by Phex.. Biochemical and biophysical research communications, (13): [PMID:12220505] |
| 56. Basrur, Venkatesha V and 12 more authors.. () Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.. Journal of proteome research, [PMID:12643545] |
| 57. Otsuki, Tetsuji T and 24 more authors.. (2005) Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries.. DNA research : an international journal for rapid publication of reports on genes and genomes, [PMID:16303743] |
| 58. Liu, Jian-Ping JP and 5 more authors.. (2006) Human homologue of SETA binding protein 1 interacts with cathepsin B and participates in TNF-Induced apoptosis in ovarian cancer cells.. Molecular and cellular biochemistry, [PMID:16733801] |
| 59. Chi, An A and 16 more authors.. (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.. Journal of proteome research, [PMID:17081065] |
| 60. Yadav, Mange R MR, Shinde, Anil K AK, Chouhan, Bishram S BS, Giridhar, Rajani R and Menard, Robert R.. (2008) Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.. Journal of enzyme inhibition and medicinal chemistry, [PMID:18343903] |
| 61. Royer-Zemmour, Barbara B and 11 more authors.. (2008) Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR.. Human molecular genetics, (1): [PMID:18718938] |
| 62. Bian, Yangyang Y and 9 more authors.. (2014) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.. Journal of proteomics, (16): [PMID:24275569] |
| 63. Ngcungcu, Thandiswa T and 28 more authors.. (2017) Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families.. American journal of human genetics, (4): [PMID:28457472] |
